However, while our study found C8B upregulation in BLCA, the meta-analysis reported downregulation of C8B and other complement regulators in BLCA, possibly due to sample differences, tumor heterogeneity, or variations between transcriptomic and proteomic analyses [52]. The gene discussed is C8B; the disease is bladder transitional cell carcinoma.